Jubilant Cadista Pharmaceuticals, Inc. is recalling approximately 119,008 bottles of Itraconazole Capsules (100 mg), a prescription antifungal medication. This recall was initiated because the drug failed dissolution testing, meaning the capsules may not dissolve properly in the body as intended. If the medication does not dissolve correctly, the patient may not receive the full therapeutic dose, which could lead to ineffective treatment of fungal infections. These products were distributed nationwide in 30-count bottles and were manufactured in India.
The product failed dissolution specifications, which can prevent the active ingredient from being properly absorbed by the body, potentially resulting in under-dosing and the failure of the antifungal treatment.
Healthcare consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.